Literature DB >> 18439591

Dehydroepiandrosterone sulfate and insulin resistance in patients with polycystic ovary syndrome.

Kathleen Brennan1, Andy Huang, Ricardo Azziz.   

Abstract

OBJECTIVE: To test the hypothesis that increasing DHEAS levels is associated with improved insulin resistance in patients with polycystic ovary syndrome (PCOS).
DESIGN: Cross-sectional cohort analysis.
SETTING: Academic medical center. PATIENT(S): Three hundred fifty-two women with PCOS. INTERVENTION(S): Patients presenting for evaluation of symptoms related to androgen excess were evaluated physically and biochemically through laboratory analysis. MAIN OUTCOME MEASURE(S): Circulating DHEAS, total T, free T, sex hormone-binding globulin (SHBG), and 17-hydroxyprogesterone (17-OHP) levels, and calculated homeostasis model assessment of insulin resistance (HOMA-IR). RESULT(S): Bivariate analysis indicated that all parameters were associated with HOMA-IR, except 17-OHP and age, and confirmed a negative correlation between DHEAS and HOMA-IR. Multivariate analysis indicated that increases in DHEAS, SHBG, 17-OHP, and age were associated with decreasing HOMA-IR, whereas increases in free T, body mass index (BMI), and waist-to-hip ratio (WHR) were associated with increasing HOMA-IR. In decreasing order of importance, the following variables predicted insulin resistance: BMI > WHR > age > DHEAS > free T > SHBG > 17-OHP. CONCLUSION(S): DHEAS is negatively correlated to insulin resistance in patients with PCOS, and in our model ranked just behind other well-established predictors including BMI, WHR, and age. Whether this is due to a direct beneficial effect on insulin action by adrenal androgens such as DHEA, or whether DHEAS simply reflects the circulating levels of hyperinsulinemia, remains to be determined.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18439591      PMCID: PMC2691796          DOI: 10.1016/j.fertnstert.2008.02.101

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  33 in total

1.  Low dehydroepiandrosterone and ischemic heart disease in middle-aged men: prospective results from the Massachusetts Male Aging Study.

Authors:  H A Feldman; C B Johannes; A B Araujo; B A Mohr; C Longcope; J B McKinlay
Journal:  Am J Epidemiol       Date:  2001-01-01       Impact factor: 4.897

2.  A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain.

Authors:  M Asunción; R M Calvo; J L San Millán; J Sancho; S Avila; H F Escobar-Morreale
Journal:  J Clin Endocrinol Metab       Date:  2000-07       Impact factor: 5.958

3.  Testosterone-binding levels in the serum of women during the normal menstrual cycle, pregnancy, and the post-partum period.

Authors:  W H Pearlman; O Crépy; M Murphy
Journal:  J Clin Endocrinol Metab       Date:  1967-07       Impact factor: 5.958

4.  A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.

Authors:  E Diamanti-Kandarakis; C R Kouli; A T Bergiele; F A Filandra; T C Tsianateli; G G Spina; E D Zapanti; M I Bartzis
Journal:  J Clin Endocrinol Metab       Date:  1999-11       Impact factor: 5.958

Review 5.  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

Authors: 
Journal:  Hum Reprod       Date:  2004-01       Impact factor: 6.918

6.  Hirsutism: implications, etiology, and management.

Authors:  R Hatch; R L Rosenfield; M H Kim; D Tredway
Journal:  Am J Obstet Gynecol       Date:  1981-08-01       Impact factor: 8.661

7.  Failure of mathematical indices to accurately assess insulin resistance in lean, overweight, or obese women with polycystic ovary syndrome.

Authors:  Evanthia Diamanti-Kandarakis; Chryssa Kouli; Krystallenia Alexandraki; Giovanna Spina
Journal:  J Clin Endocrinol Metab       Date:  2004-03       Impact factor: 5.958

8.  Glucose action and adrenocortical biosynthesis in women with polycystic ovary syndrome.

Authors:  Lisa Farah-Eways; Rosario Reyna; Eric S Knochenhauer; Alfred A Bartolucci; Ricardo Azziz
Journal:  Fertil Steril       Date:  2004-01       Impact factor: 7.329

9.  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.

Authors: 
Journal:  Fertil Steril       Date:  2004-01       Impact factor: 7.329

10.  The prevalence and features of the polycystic ovary syndrome in an unselected population.

Authors:  Ricardo Azziz; Keslie S Woods; Rosario Reyna; Timothy J Key; Eric S Knochenhauer; Bulent O Yildiz
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

View more
  13 in total

1.  Prevalence and impact of hyperandrogenemia in 1,218 women with polycystic ovary syndrome.

Authors:  Sarantis Livadas; Christos Pappas; Athanasios Karachalios; Evangelos Marinakis; Nikoleta Tolia; Maria Drakou; Philippos Kaldrymides; Dimitrios Panidis; Evanthia Diamanti-Kandarakis
Journal:  Endocrine       Date:  2014-04-22       Impact factor: 3.633

Review 2.  Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome.

Authors:  Daniel A Dumesic; Sharon E Oberfield; Elisabet Stener-Victorin; John C Marshall; Joop S Laven; Richard S Legro
Journal:  Endocr Rev       Date:  2015-10       Impact factor: 19.871

3.  Eight common genetic variants associated with serum DHEAS levels suggest a key role in ageing mechanisms.

Authors:  Guangju Zhai; Alexander Teumer; Lisette Stolk; John R B Perry; Liesbeth Vandenput; Andrea D Coviello; Annemarie Koster; Jordana T Bell; Shalender Bhasin; Joel Eriksson; Anna Eriksson; Florian Ernst; Luigi Ferrucci; Timothy M Frayling; Daniel Glass; Elin Grundberg; Robin Haring; Asa K Hedman; Albert Hofman; Douglas P Kiel; Heyo K Kroemer; Yongmei Liu; Kathryn L Lunetta; Marcello Maggio; Mattias Lorentzon; Massimo Mangino; David Melzer; Iva Miljkovic; Alexandra Nica; Brenda W J H Penninx; Ramachandran S Vasan; Fernando Rivadeneira; Kerrin S Small; Nicole Soranzo; André G Uitterlinden; Henry Völzke; Scott G Wilson; Li Xi; Wei Vivian Zhuang; Tamara B Harris; Joanne M Murabito; Claes Ohlsson; Anna Murray; Frank H de Jong; Tim D Spector; Henri Wallaschofski
Journal:  PLoS Genet       Date:  2011-04-14       Impact factor: 5.917

4.  Association of insulin resistance with lipid profile, metabolic syndrome, and hormonal aberrations in overweight or obese women with polycystic ovary syndrome.

Authors:  Mehranghiz Ebrahimi-Mamaghani; Maryam Saghafi-Asl; Saeed Pirouzpanah; Akbar Aliasgharzadeh; Soudabeh Aliashrafi; Niloufar Rezayi; Mahzad Mehrzad-Sadaghiani
Journal:  J Health Popul Nutr       Date:  2015-03       Impact factor: 2.000

5.  Hyperandrogenemia in polycystic ovary syndrome: exploration of the role of free testosterone and androstenedione in metabolic phenotype.

Authors:  Elisabeth Lerchbaum; Verena Schwetz; Thomas Rabe; Albrecht Giuliani; Barbara Obermayer-Pietsch
Journal:  PLoS One       Date:  2014-10-13       Impact factor: 3.240

6.  Insulin resistance and endocrine-metabolic abnormalities in polycystic ovarian syndrome: Comparison between obese and non-obese PCOS patients.

Authors:  Parvin Layegh; Zohreh Mousavi; Donya Farrokh Tehrani; Seyed Mohammad Reza Parizadeh; Mohammad Khajedaluee
Journal:  Int J Reprod Biomed (Yazd)       Date:  2016-04

7.  Limitations of insulin resistance assessment in polycystic ovary syndrome.

Authors:  Krzysztof C Lewandowski; Justyna Płusajska; Wojciech Horzelski; Ewa Bieniek; Andrzej Lewiński
Journal:  Endocr Connect       Date:  2018-02-07       Impact factor: 3.335

8.  Adrenocortical steroid response to ACTH in different phenotypes of non-obese polycystic ovary syndrome.

Authors:  Nese Cinar; Ayla Harmanci; Duygu Yazgan Aksoy; Kadriye Aydin; Bulent Okan Yildiz
Journal:  J Ovarian Res       Date:  2012-12-07       Impact factor: 4.234

9.  The effect of androgens on ovarian follicle maturation: Dihydrotestosterone suppress FSH-stimulated granulosa cell proliferation by upregulating PPARγ-dependent PTEN expression.

Authors:  Mei-Jou Chen; Chia-Hung Chou; Shee-Uan Chen; Wei-Shiung Yang; Yu-Shih Yang; Hong-Nerng Ho
Journal:  Sci Rep       Date:  2015-12-17       Impact factor: 4.379

10.  Dehydroepiandrosterone-Sulfate, Insulin Resistance and Ovarian Volume Estimation in Patients With Polycystic Ovarian Syndrome.

Authors:  Chrysi Christodoulaki; Eftihios Trakakis; Vasilios Pergialiotis; Periklis Panagopoulos; Charalampos Chrelias; Dimitrios Kassanos; Dimos Sioutis; Nikolaos Papantoniou; Dimitrios Xirofotos
Journal:  J Family Reprod Health       Date:  2017-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.